ECOR vs STXS: stock comparison and AI forecast
Electrocore, Inc. (ECOR) and Stereotaxis, Inc. (STXS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ECOR Electrocore, Inc.
- Price
- $8.80 +40.4% · 6M
- Market Cap
- $79M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
STXS Stereotaxis, Inc.
- Market Cap
- $105M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- STXS is 1.3 times larger than ECOR by market capitalization ($105M against $79M).
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ECOR | STXS |
|---|---|---|
| Market Cap | $79M | $105M |
| EPS | $-1.38 | $-0.25 |
| Revenue/Share | $4.21 | $0.30 |
| FCF/Share | $-1.21 | $-0.15 |
Profitability & Margins
| Metric | ECOR | STXS |
|---|---|---|
| ROA | -73.6% | – |
| ROIC | -194.3% | – |
| Gross Margin | 87.7% | 55.3% |
| Operating Margin | -33.1% | -75.3% |
| Net Margin | -33.5% | – |
| EBT Margin | -34.5% | -75.3% |
| Tax Rate | 3.0% | – |
Financial Health
| Metric | ECOR | STXS |
|---|---|---|
| Current Ratio | 1.34x | 1.42x |
| Quick Ratio | 0.97x | 0.95x |
| Interest Coverage | -420.5x | -45.7x |
| Working Capital | $4M | $11M |
Cash Flow
| Metric | ECOR | STXS |
|---|---|---|
| Operating Cash Flow | -$11M | -$15M |
| Free Cash Flow | -$11M | -$16M |
| Capital Spending | -$10K | -$210K |
| FCF/Sales | -28.7% | -51.6% |
| CapEx/Sales | 0.0% | 0.7% |
Operational Efficiency
| Metric | ECOR | STXS |
|---|---|---|
| Asset Turnover | 2.20x | – |
| Receivables Turnover | 23.4x | 4.0x |
| Inventory Turnover | 1.2x | 1.1x |
| Fixed Assets Turnover | 102.3x | 10.4x |
| Days Sales Outstanding | 16 days | 92 days |
| Days Inventory | 309 days | 342 days |
| Payables Period | 268 days | 188 days |
| Cash Conversion Cycle | 56 days | 246 days |
Income Statement
| Metric | ECOR | STXS |
|---|---|---|
| Total Revenue | $38M | $30M |
| Operating Income | -$13M | -$23M |
| Net Income | -$13M | – |
| R&D Expense | $3M | $10M |
| SG&A Expense | $43M | $46M |
| Cost of Goods Sold | $5M | $13M |
Dividend & Shareholder Information
| Metric | ECOR | STXS |
|---|---|---|
| Shares Outstanding | 9M | 100M |
ECOR vs STXS: stock comparison and AI forecast
Which is bigger, ECOR or STXS?
STXS is 1.3 times larger than ECOR by market capitalization ($105M against $79M).
Which one does Intratio's AI model rank higher, ECOR or STXS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.